AB 747

  • Wisconsin Assembly Bill
  • 2023-2024 Regular Session
  • Introduced in Assembly Dec 06, 2023
  • Assembly
  • Senate
  • Governor

Relating to: creating a Prescription Drug Affordability Review Board, funding for an office of prescription drug affordability, crediting certain amounts to the general program operations account of the office of the commissioner of insurance, granting rulemaking authority, and making an appropriation. (FE)

Votes


No votes to display

Actions


Apr 15, 2024

Assembly

Failed to pass pursuant to Senate Joint Resolution 1

Dec 18, 2023

Assembly

Fiscal estimate received

Dec 06, 2023

Assembly

Introduced by Representatives Subeck, C. Anderson, J. Anderson, Andraca, Bare, Billings, Clancy, Conley, Considine, Drake, Emerson, Hong, Jacobson, Joers, Moore Omokunde, Neubauer, Ortiz-Velez, Palmeri, Ratcliff, Shankland, Shelton, Sinicki, Haywood and Madison; cosponsored by Senators Pfaff, Hesselbein, Agard, Carpenter, L. Johnson, Larson, Roys, Smith, Spreitzer, Taylor and Wirch

Assembly

Read first time and referred to Committee on Insurance

Bill Text

Bill Text Versions Format
Bill Text PDF HTML

Related Documents

Document Format
2023 Senate Bill 718 HTML
Wisconsin Ethics Commission information HTML
AB747 ROCP for Committee on Insurance HTML
AB747: Fiscal Estimate From OCI

Sources

Data on Open States is updated periodically throughout the day from the official website of the Wisconsin State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.